Forum.
- Published in:
- Pharmaceutical Medicine, 2017, v. 31, n. 4, p. 279, doi. 10.1007/s40290-017-0193-7
- Publication type:
- Article
Works matching IS 11782595 AND DT 2017 AND VI 31 AND IP 4
Results: 8
1
2
Major Pharmaceutical Conferences and Courses.
- Published in:
- Pharmaceutical Medicine, 2017, v. 31, n. 4, p. 293, doi. 10.1007/s40290-017-0194-6
- Publication type:
- Article
3
Assessing the Value of System Theoretic Process Analysis in a Pharmacovigilance Process: An Example Using Signal Management.
- Published in:
- Pharmaceutical Medicine, 2017, v. 31, n. 4, p. 267, doi. 10.1007/s40290-017-0195-5
- By:
- Publication type:
- Article
4
Measuring and Improving Physician Knowledge of Safety Risks Using Traditional and Online Methods in Pharmacovigilance.
- Published in:
- Pharmaceutical Medicine, 2017, v. 31, n. 4, p. 257, doi. 10.1007/s40290-017-0196-4
- By:
- Publication type:
- Article
5
Different Weights of the Evidence-Based Medicine Triad in Regulatory, Health Technology Assessment, and Clinical Decision Making.
- Published in:
- Pharmaceutical Medicine, 2017, v. 31, n. 4, p. 213, doi. 10.1007/s40290-017-0197-3
- By:
- Publication type:
- Article
6
Challenges in Conducting Clinical Trials for Pharmacotherapies in Fragile X Syndrome: Lessons Learned.
- Published in:
- Pharmaceutical Medicine, 2017, v. 31, n. 4, p. 235, doi. 10.1007/s40290-017-0199-1
- By:
- Publication type:
- Article
7
Risk Perceptions in Diabetic Patients Who Have Experienced Adverse Events: Implications for Patient Involvement in Regulatory Decisions.
- Published in:
- Pharmaceutical Medicine, 2017, v. 31, n. 4, p. 245, doi. 10.1007/s40290-017-0200-z
- By:
- Publication type:
- Article
8
Integrating Genomics into Drug Discovery and Development: Challenges and Aspirations.
- Published in:
- Pharmaceutical Medicine, 2017, v. 31, n. 4, p. 217, doi. 10.1007/s40290-017-0192-8
- By:
- Publication type:
- Article